Fig. 3From: Identification of four snoRNAs (SNORD16, SNORA73B, SCARNA4, and SNORD49B) as novel non-invasive biomarkers for diagnosis of breast cancerPlasma snoRNAs: SNORD16, SNORA73B, SCARNA4, and SNORD49B as biomarkers for BC diagnosis. (A) The differential expressions of plasma SNORD16, SNORA73B, SCARNA4, and SNORD49B were analyzed between BC patients and health donors. The AUCs of plasma SNORD16 (B), SNORA73B (C), SCARNA4 (D), and SNORD49B (E) were 0.7334, 0.7165, 0.6880, and 0.6728, respectively. (F) The diagnostic performance for their combination demonstrated an AUC of 0.7521. ****P < 0.0001Back to article page